SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950157-22-001253
Filing Date
2022-11-29
Accepted
2022-11-29 08:29:44
Documents
14
Period of Report
2022-11-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8-k.htm   iXBRL 8-K 44889
2 AMENDMENT NO. 1 TO TRANSACTION AGREEMENT ex2-1.htm EX-2.1 174908
3 PRESS RELEASE ex99-1.htm EX-99.1 25308
  Complete submission text file 0000950157-22-001253.txt   420010

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20221128.xsd EX-101.SCH 3920
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20221128_lab.xml EX-101.LAB 22544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20221128_pre.xml EX-101.PRE 16040
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4054
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 221428541
SIC: 2834 Pharmaceutical Preparations